SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-24-001261
Filing Date
2024-05-16
Accepted
2024-05-16 17:06:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO THE SCHEDULE 13D sc13da412927011_05162024.htm SC 13D/A 207790
  Complete submission text file 0000921895-24-001261.txt   209408
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Subject) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85452 | Film No.: 24956616
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 NORTH MAIN STREET SUITE 301 ALPHARETTA GA 30009
Business Address 100 NORTH MAIN STREET SUITE 301 ALPHARETTA GA 30009 646-844-0037
Velan Capital Investment Management LP (Filed by) CIK: 0001848809 (see all company filings)

IRS No.: 844706623 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A